Sandoz Conseil Doxylamine 15mg

Sandoz Conseil Doxylamine is a pharmaceutical sleep aid containing doxylamine hydrogenosuccinate, used primarily for the occasional treatment of insomnia in adults. The brand Sandoz has a deep historical root in Switzerland, dating back to the late 19th century.

Historically, Sandoz became part of the massive Novartis group after a merger with Ciba-Geigy in 1996. However, in October 2023, Sandoz was successfully spun off as an independent, publicly traded company specializing in generic pharmaceuticals and biosimilars. While headquartered in Basel, Switzerland, Sandoz operates an extensive global supply chain, with manufacturing sites across Europe and other continents. This specific packaging, featuring French labeling, indicates distribution within the French-speaking market through its local healthcare networks.